Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Sleeve Gastrectomy Tied to Improved Vascular Markers

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening.

Proposed Act Would Fill Gaps in Cancer Survivorship Care

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Low-Dose Aspirin Underutilized as Preeclampsia Prevention

Women at high risk for preeclampsia often do not receive recommended preventive treatment.

Even Low HIV Load Can Double Heart Disease Risk

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

EU Widens Access for Rare Lipid and Obesity Disorders

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Health Risk May Vary by Alcohol Type

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Latest News

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening.

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Women at high risk for preeclampsia often do not receive recommended preventive treatment.

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

News All Time

Novel Wearable Detects Aortic Stenosis

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

Air Pollution Tied to Myocardial Fibrosis in Normal Hearts

Chronic exposure to fine particulate matter is associated with changes in cardiac magnetic resonance markers of early myocardial fibrosis in patients with structurally normal hearts.

EMA Backs Orodispersible Furosemide for Edema in Children

The European regulator recommends granting pediatric use marketing authorization for Bopediat to treat children with oedema and hypertension from chronic kidney disease.

Anti-VEGF Injections Safe Around CVD Events

Receiving anti VEGF eye injections around the time of a stroke or heart attack is not linked to an increased risk for death or major complications, a study finds.

Placental Abruption Linked to Heart Disease in Teens

Cardiovascular disease shows up as early as within the first year of life.

GI Bleeding Deaths Rise in Wake of Increased DOAC Use

Deaths from gastrointestinal bleeding have increased, but fatal bleeding risk per anticoagulated patient has declined despite the widespread use of direct oral anticoagulants.

Filtration Defect in Kidneys May Identify Heart Risk in T1D

Shrunken pore syndrome, a renal filtration defect, is associated with an increased risk for cardiovascular disease and death in patients with T1D without albuminuria.

Few Prescribing for Elevated Lp(a) in Low-Risk Patients

Most clinicians take no preventive action when a low-risk patient presents with elevated levels of lipoprotein(a), but 1 in 5 clinicians initiate preventive pharmacotherapy.

What Is Delaying Movement in Managing Gastroparesis?

Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are moving forward.

New Tool Predicts Cardiometabolic Risk in Psychosis

A web-based risk prediction tool can forecast weight gain, metabolic syndrome, and diabetes years in advance in young adults with psychosis, which may provide an opportunity for earlier intervention.

Ultraprocessed Foods Increase Risk of Heart Problems

Each serving of ultraprocessed food increased risk of cardiac events by 5%.

Inflammation May Explain Link Between Belly Fat, HF

Excess abdominal fat — not overall body weight — may drive heart failure risk, with systemic inflammation being partially to blame.

Arterial Stiffness Changes Linked to Developing Dementia

Pulse wave velocity, calculated from age and blood pressure changes, was associated with significant dementia risk in a post hoc SPRINT analysis.

In High-BP Patients, Lifestyle Tied to Cardiometabolic Risk

Maintaining a healthy lifestyle was associated with a lower risk for major cardiometabolic diseases, regardless of antihypertensive medication use.

Triple Agonist Retatrutide Reduces A1c, Weight in T2D

Eli Lilly and Company report top-line phase 3 clinical trial results for its investigational GLP-1, GIP, and glucagon agonist in people with type 2 diabetes.

Tool Spots Heart Failure Risk Missed in Patients With ASCVD

A risk model predicts the risk for heart failure in patients with atherosclerotic cardiovascular disease and flags a notable proportion classified as low risk by other risk tools.

Recommended News For You

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

The importance of breast cancer screening

Biomarker panel offers hope for early pancreatic cancer detection

Sports for girls are frequently abandoned due to uniform issues.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Recommended Articles For You

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment  

Obesity as a major risk factor for cancer 

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment 

Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia

2.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

3.

Climate change is expected to increase the number of suicide deaths

4.

Cancer care crowdfunding increasingly common, but rarely successful

5.

Using AI, one can find cancer risk factors.

1.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

2.

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection

3.

Understanding Fibrosarcoma: What You Need to Know 

4.

The Benefits and Side Effects of Vidaza Syndrome 

5.

Unraveling the Genetic Mystery of Hereditary Spherocytosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

2.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot